Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Monitoring early tumor response to drug therapy with diffuse optical tomography.

Flexman ML, Vlachos F, Kim HK, Sirsi SR, Huang J, Hernandez SL, Johung TB, Gander JW, Reichstein AR, Lampl BS, Wang A, Borden MA, Yamashiro DJ, Kandel JJ, Hielscher AH.

J Biomed Opt. 2012 Jan;17(1):016014. doi: 10.1117/1.JBO.17.1.016014.

2.

Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy.

Sirsi SR, Flexman ML, Vlachos F, Huang J, Hernandez SL, Kim HK, Johung TB, Gander JW, Reichstein AR, Lampl BS, Wang A, Hielscher AH, Kandel JJ, Yamashiro DJ, Borden MA.

Ultrasound Med Biol. 2012 Jun;38(6):1019-29. doi: 10.1016/j.ultrasmedbio.2012.01.014. Epub 2012 Mar 16.

3.

Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy.

Bhuvaneswari R, Thong PS, Gan YY, Soo KC, Olivo M.

J Biomed Opt. 2010 Jan-Feb;15(1):011114. doi: 10.1117/1.3281671. Erratum in: J Biomed Opt. 2010 Mar-Apr;15(2):029802. Soo, Khee [corrected to Soo, Khee-Chee].

PMID:
20210440
4.

Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy.

Guibal A, Taillade L, Mulé S, Comperat E, Badachi Y, Golmard JL, Le Guillou-Buffello D, Rixe O, Bridal SL, Lucidarme O.

Radiology. 2010 Feb;254(2):420-9. doi: 10.1148/radiol.09090728.

PMID:
20093514
5.

Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.

Patterson DM, Gao D, Trahan DN, Johnson BA, Ludwig A, Barbieri E, Chen Z, Diaz-Miron J, Vassilev L, Shohet JM, Kim ES.

Angiogenesis. 2011 Sep;14(3):255-66. doi: 10.1007/s10456-011-9210-8. Epub 2011 Apr 12.

PMID:
21484514
6.

Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts.

Miyazaki S, Kikuchi H, Iino I, Uehara T, Setoguchi T, Fujita T, Hiramatsu Y, Ohta M, Kamiya K, Kitagawa K, Kitagawa M, Baba S, Konno H.

Int J Cancer. 2014 Jul 15;135(2):295-307. doi: 10.1002/ijc.28686. Epub 2014 Jan 6.

7.

Phage display peptide probes for imaging early response to bevacizumab treatment.

Cao Q, Liu S, Niu G, Chen K, Yan Y, Liu Z, Chen X.

Amino Acids. 2011 Nov;41(5):1103-12. doi: 10.1007/s00726-010-0548-9. Epub 2010 Mar 16.

8.

CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.

Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.

Cancer Res. 2003 Sep 15;63(18):5978-91. Erratum in: Cancer Res. 2003 Nov 1;63(21):7543.

9.

Dynamic gadobutrol-enhanced MRI predicts early response to antivascular but not to antiproliferation therapy in a mouse xenograft model.

Dassler K, Scholle FD, Schütz G.

Magn Reson Med. 2014 May;71(5):1826-33. doi: 10.1002/mrm.24815. Epub 2013 Jun 10.

PMID:
23754607
10.
11.

Non-invasive monitoring of hypoxia-inducible factor activation by optical imaging during antiangiogenic treatment in a xenograft model of ovarian carcinoma.

Martinez-Poveda B, Gomez V, Alcaide-German M, Perruca S, Vazquez S, Alba LE, Casanovas O, Garcia-Bermejo ML, Peso L, Jimenez B.

Int J Oncol. 2011 Sep;39(3):543-52. doi: 10.3892/ijo.2011.1074. Epub 2011 Jun 9.

PMID:
21667025
12.

Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.

Bota DA, Alexandru D, Keir ST, Bigner D, Vredenburgh J, Friedman HS.

J Neurosurg. 2013 Dec;119(6):1415-23. doi: 10.3171/2013.7.JNS1323. Epub 2013 Oct 4.

13.

Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma.

Bausch D, Pausch T, Krauss T, Hopt UT, Fernandez-del-Castillo C, Warshaw AL, Thayer SP, Keck T.

Angiogenesis. 2011 Sep;14(3):235-43. doi: 10.1007/s10456-011-9207-3. Epub 2011 Mar 26.

14.

MicroPET imaging of tumor angiogenesis and monitoring on antiangiogenic therapy with an (18)F labeled RGD-based probe in SKOV-3 xenograft-bearing mice.

Yang G, Nie P, Kong Y, Sun H, Hou G, Han J.

Tumour Biol. 2015 May;36(5):3285-91. doi: 10.1007/s13277-014-2958-x. Epub 2014 Dec 13.

PMID:
25501513
16.

Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.

Zhu W, Kato Y, Artemov D.

MAGMA. 2014 Apr;27(2):161-70. doi: 10.1007/s10334-013-0389-0. Epub 2013 Jun 27.

17.

Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumab.

Weisshardt P, Trarbach T, Dürig J, Paul A, Reis H, Tilki D, Miroschnik I, Ergün S, Klein D.

Histochem Cell Biol. 2012 Mar;137(3):391-401. doi: 10.1007/s00418-011-0898-8. Epub 2011 Dec 23.

PMID:
22193946
18.

Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models.

Navis AC, Hamans BC, Claes A, Heerschap A, Jeuken JW, Wesseling P, Leenders WP.

J Pathol. 2011 Apr;223(5):626-34. doi: 10.1002/path.2836. Epub 2011 Feb 21.

PMID:
21341272
19.

Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma.

Wakamatsu T, Naka N, Sasagawa S, Tanaka T, Takenaka S, Araki N, Ueda T, Nishizawa Y, Yoshikawa H, Itoh K.

Cancer Sci. 2014 Sep;105(9):1124-34. doi: 10.1111/cas.12469. Epub 2014 Sep 3.

20.

Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells.

Gao H, Xue J, Zhou L, Lan J, He J, Na F, Yang L, Deng L, Lu Y.

Cancer Lett. 2015 Aug 28;365(1):79-88. doi: 10.1016/j.canlet.2015.05.011. Epub 2015 May 13.

PMID:
25982206

Supplemental Content

Support Center